A Preliminary Analysis of Oral Edaravone-Treated Patients With Amyotrophic Lateral Sclerosis Enrolled in a US-Based Administrative Claims Database

被引：0
|
作者：
Ciepielewska, Malgorzata [1 ]
Zhang, Jeffrey [2 ]
Liu, Ying [2 ]
Da Silva, Polina [1 ]
机构：
[1] Mitsubishi Tanabe Pharma Amer, Jersey City, NJ USA
[2] Princeton Pharmatech LLC, Princeton, NJ USA
来源：
MUSCLE & NERVE | 2023年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
115
引用
收藏
页码：S54 / S55
页数：2
相关论文
共 50 条
  • [1] A PRELIMINARY ANALYSIS OF ORAL EDARAVONE-TREATED PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS ENROLLED IN A US-BASED ADMINISTRATIVE CLAIMS DATABASE
    Ciepielewska, M.
    Zhang, J.
    Liu, Y.
    Da, Silva P.
    [J]. VALUE IN HEALTH, 2024, 27 (06) : S45 - S46
  • [2] Longer milestone-free time in IV edaravone-treated vs non-IV edaravone-treated patients with amyotrophic lateral sclerosis: An administrative claims analysis
    Berry, James D.
    Hagan, Melissa
    Ciepielewska, Malgorzata
    Zhang, Jeffrey
    Liu, Ying
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
  • [3] Time to Event Milestones in Patients With Amyotrophic Lateral Sclerosis Treated With IV Edaravone: Results From a US Administrative Claims Analysis
    Hagan, Melissa
    Ciepielewska, Malgorzata
    Harrison, Antoinette
    Liu, Ying
    Zhang, Jeffrey
    Apple, Stephen
    [J]. NEUROLOGY, 2021, 96 (15)
  • [4] Longer Milestone-Free Time in Patients With Amyotrophic Lateral Sclerosis Treated With IV Edaravone vs Not Treated With IV Edaravone: Results From a US Administrative Claims Analysis
    Ciepielewska, Malgorzata
    Zhang, Jeffrey
    Liu, Ying
    Hagan, Melissa
    [J]. NEUROLOGY, 2023, 100 (17)
  • [5] Longer Milestone-free Time in Patients With Amyotrophic Lateral Sclerosis Treated With IV Edaravone vs IV Edaravone-naive: Results From an Administrative Claims Analysis
    Berry, James
    Hagan, Melissa
    Ciepielewska, Malgorzata
    Zhang, Jeffrey
    Liu, Ying
    [J]. MUSCLE & NERVE, 2022, 66 : S50 - S50
  • [6] Pharmacokinetics of Edaravone Oral Suspension in Patients With Amyotrophic Lateral Sclerosis
    Shimizu, Hidetoshi
    Nishimura, Yukiko
    Shiide, Youichi
    Akimoto, Makoto
    Yashiro, Makiko
    Ueda, Masaki
    Hirai, Manabu
    Yoshino, Hiide
    Mizutani, Tomohiko
    Kanai, Kazuaki
    Kano, Osamu
    Kimura, Hideki
    Sekino, Hisakuni
    Ito, Kimiko
    [J]. CLINICAL THERAPEUTICS, 2023, 45 (12) : 1251 - 1258
  • [7] Survival in Amyotrophic Lateral Sclerosis Patients Treated with Edaravone - a Pooled Analysis of 2845 Patients
    Nourelden, Anas
    Kamal, Ibrahim
    Tawfik, Abdelrahman G.
    Elhady, Mahmoud M.
    Hagrass, Abdulrahman
    Fathallah, Ahmed Hashem
    Zaazouee, Mohamed
    [J]. NEUROLOGY, 2023, 100 (17)
  • [8] Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database
    Williams, James R.
    Fitzhenry, David
    Grant, Lauren
    Martyn, Derek
    Kerr, Douglas A.
    [J]. BMC NEUROLOGY, 2013, 13
  • [9] Diagnosis pathway for patients with amyotrophic lateral sclerosis: retrospective analysis of the US Medicare longitudinal claims database
    James R Williams
    David Fitzhenry
    Lauren Grant
    Derek Martyn
    Douglas A Kerr
    [J]. BMC Neurology, 13
  • [10] Identifying disability level in multiple sclerosis patients in a US-based health plan claims database
    Berkovich, R.
    Fox, E.
    Okai, A.
    Ding, Y.
    Gorritz, M.
    Bartolome, L.
    Wade, R. L.
    Su, W.
    Russo, P.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 113 - 114
12345